Several banks, such as Goldman Sachs and Citigroup, have initiated a debt sale totaling €7.45 billion ($8.1 billion) to support Clayton Dubilier & Rice’s acquisition of a share in Sanofi SA's consumer health division.

The debt offering comprises euro- and dollar-denominated leveraged loans amounting to €5.45 billion equivalent. Additionally, lenders are promoting bonds totaling €2 billion equivalent, with at least half of them in euros.

The financing is being managed by global coordinators including Citigroup, Goldman Sachs, Barclays Plc, BNP Paribas SA, Morgan Stanley, Societe Generale SA, and HSBC Holdings Plc, as informed by insiders.

The banks initiated the pre-marketing of the anticipated financing deal earlier in the week. A successful completion of this sale would bring a sense of relief to the banks, who have held onto the debt for approximately six months. Discussions with investors are scheduled for Monday.

This deal is occurring amidst financial market turbulence caused by US President Donald Trump's trade conflicts, leading to economic uncertainties globally. Recent developments have seen companies in Europe and the US refrain from entering the riskiest sections of the loan market, although only selective opportunistic deals have been withdrawn thus far.